First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
Clinical trial NCT05335811 · RECRUITING
Trial details
- NCT number
- NCT05335811
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2028-08-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.